BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24285218)

  • 1. Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair.
    Alaee F; Sugiyama O; Virk MS; Tang H; Drissi H; Lichtler AC; Lieberman JR
    Gene Ther; 2014 Feb; 21(2):139-47. PubMed ID: 24285218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
    Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
    Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.
    Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T
    Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo gene therapy using human bone marrow cells overexpressing BMP-2: "Next-day" gene therapy versus standard "two-step" approach.
    Bougioukli S; Alluri R; Pannell W; Sugiyama O; Vega A; Tang A; Skorka T; Park SH; Oakes D; Lieberman JR
    Bone; 2019 Nov; 128():115032. PubMed ID: 31398502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral vector mediated thymidine kinase expression in pluripotent stem cells enables removal of tumorigenic cells.
    Lim TT; Geisen C; Hesse M; Fleischmann BK; Zimmermann K; Pfeifer A
    PLoS One; 2013; 8(7):e70543. PubMed ID: 23936225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells.
    Hossain JA; Ystaas LR; Mrdalj J; Välk K; Riecken K; Fehse B; Bjerkvig R; Grønli J; Miletic H
    J Gene Med; 2016 Sep; 18(9):234-43. PubMed ID: 27490042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification.
    Jiang YX; Lu Y; Liu TJ; Yang J; Chen Y; Fang YW
    Mol Vis; 2011 Jan; 17():291-9. PubMed ID: 21283526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Suicide Gene Therapy with TK.007.
    Hossain JA; Riecken K; Miletic H; Fehse B
    Methods Mol Biol; 2019; 1895():11-26. PubMed ID: 30539526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
    Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
    Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q
    In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated ex vivo regional gene therapy for bone repair using an inducible caspase-9 suicide gene system.
    Bougioukli S; Vakhshori V; Ortega B; Sugiyama O; Lieberman J
    Gene Ther; 2019 Jun; 26(6):230-239. PubMed ID: 30962534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].
    Xu KL; Zhu F; Du B; Gao F; Cheng H; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):303-7. PubMed ID: 17877157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
    J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.
    Kuo WY; Hwu L; Wu CY; Lee JS; Chang CW; Liu RS
    Theranostics; 2017; 7(3):647-663. PubMed ID: 28255357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-directed double suicide gene therapy targeting of MUC1- positive leukemia cells in vitro and in vivo.
    Dong XY; Wang WQ; Zhao Y; Li XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Pan GJ; Liu JJ
    Curr Gene Ther; 2013 Oct; 13(5):346-57. PubMed ID: 24060312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
    Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
    Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models.
    Feeley BT; Conduah AH; Sugiyama O; Krenek L; Chen IS; Lieberman JR
    J Orthop Res; 2006 Aug; 24(8):1709-21. PubMed ID: 16788987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.